Loading...
Oriola Oyj
0NES.L•LSE
Healthcare
Medical - Equipment & Services
£1.09
£-0.01(-0.55%)
Oriola Oyj (0NES.L) Financial Performance & Income Statement Overview
Review Oriola Oyj’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
12.44%
↑ 12.44%
Operating Income Growth
0.74%
↑ 0.74%
Net Income Growth
2.90%
↑ 2.90%
Operating Cash Flow Growth
303.13%
↑ 303.13%
Operating Margin
0.41%
↑ 0.41%
Gross Margin
7.16%
↑ 7.16%
Net Profit Margin
-1.32%
↓ 1.32%
ROE
-16.16%
↓ 16.16%
ROIC
3.77%
↑ 3.77%
Oriola Oyj (0NES.L) Income Statement & Financial Overview
Review Oriola Oyj's (0NES.L) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $447.10M | $440.70M | $424.40M | $439.40M |
| Cost of Revenue | $405.70M | $398.10M | $386.60M | $435.70M |
| Gross Profit | $41.40M | $42.60M | $37.80M | $3.70M |
| Gross Profit Ratio | $0.09 | $0.10 | $0.09 | $0.008 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $0.00 | $0.00 | $14.30M |
| Operating Expenses | $44.20M | $38.60M | $37.60M | -$2.00M |
| Total Costs & Expenses | $449.90M | $436.70M | $424.20M | $433.70M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $1.80M | $1.60M |
| Depreciation & Amortization | $8.70M | $3.00M | $2.80M | $2.90M |
| EBITDA | $5.90M | $7.00M | $3.00M | $8.60M |
| EBITDA Ratio | $0.01 | $0.02 | $0.007 | $0.02 |
| Operating Income | -$2.80M | $4.00M | $200000.00 | $5.70M |
| Operating Income Ratio | -$0.006 | $0.009 | $0.00 | $0.01 |
| Other Income/Expenses (Net) | -$2.50M | -$21.30M | -$2.40M | -$2.80M |
| Income Before Tax | -$5.30M | -$17.30M | -$2.20M | $4.20M |
| Income Before Tax Ratio | -$0.01 | -$0.04 | -$0.005 | $0.010 |
| Income Tax Expense | $0.00 | $500000.00 | -$300000.00 | $900000.00 |
| Net Income | -$5.40M | -$17.80M | -$1.90M | $2.00M |
| Net Income Ratio | -$0.01 | -$0.04 | -$0.004 | $0.005 |
| EPS | -$0.03 | -$0.10 | -$0.01 | $0.01 |
| Diluted EPS | -$0.03 | -$0.10 | -$0.01 | $0.01 |
| Weighted Avg Shares Outstanding | $181.41M | $181.41M | $181.41M | $181.41M |
| Weighted Avg Shares Outstanding (Diluted) | $181.42M | $181.42M | $181.42M | $181.42M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan